Loading
Latest filing published 02 Nov 2021 for NRX Pharmaceuticals, Inc., €72k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Alessandra Daigneault is a declared insider of NRX Pharmaceuticals, Inc. (board member), with filings sourced from SEC (Form 4). Between 24 May 2021 and 19 August 2021, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 2 November 2021: an option exercise of €72k, in NRX Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations